Learn about June 2025’s top biotech deals, featuring major collaborations in small molecules, protein therapeutics, and ...

Antibody therapies constitute a vast global market: currently valued at over $250 billion, the market for antibodies is ...

As startups navigate the growing biotech sector in Wales, here are five biotech companies that are making waves in 2025.

Discover what makes Paris's biotech ecosystem so successful, as it just so happens to be one of the largest biotech clusters ...

Discover the latest developments in the neuroplastogens field, including Elkedonia’s funding to address neuropsychiatric ...

Find out about the University of Edinburgh's work to convert our common plastic wast into the wildly used paracetamol.

Learn how insights and continuous therapy are transforming chronic lymphocytic leukemia care, empowering patients to live ...

Discover six kidney disease companies actively working on innovative treatments that could make a difference to patients' ...

Delve into the STAT6 degrader technology and what it could bring to inflammatory and allergic disease treatment.

In 2020, Novo Nordisk’s Canadian patent for semaglutide, the active ingredient in its blockbuster GLP-1 drugs Ozempic and Wegovy, quietly expired. The reason? A small missed maintenance fee, ...

Labiotech provides listing of 2025 biotech conferences and events purely as a service for readers. We are not responsible for any errors in dates or omissions. Please check event websites for further ...

Akouos. Akouos, founded in 2016 focuses on developing gene therapies for hearing loss.The Boston-based biotech company uses adeno-associated viral (AAV) vector-based gene therapy techniques aimed at ...